Mari Nakayama
-
- Eicosanoids and Hypertension Pharmacology 3
-
- Eicosanoids and Hypertension Pharmacology 3
-
- RNA Interference and Gene Delivery 3
- CRISPR and Genetic Engineering 2
- Receptor Mechanisms and Signaling 2
- Glycosylation and Glycoproteins Research 1
-
- Renin-Angiotensin System Studies 3
-
- Cholesterol and Lipid Metabolism 1
-
- Hormonal and reproductive studies 1
- Co-authors
- Noboru FukudaHirobumi KishiokaKatsuo KanmatsuseWen-Yang HuMasayuki YamamotoAkinori YanakaAtsushi FukumotoSonghua Zhang
- Cited by
- BiochemistryToxicology
- Journals
- Macromolecules (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Mari Nakayama
14 papers receiving 491 citations
Peers
Comparison fields: 5 of 80
- Biochemistry 36
- Toxicology 15
- Biochemistry 25
- Molecular Biology 273
- Cardiology and Cardiovascular Medicine 85
Countries citing papers authored by Mari Nakayama
This map shows the geographic impact of Mari Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Nakayama more than expected).
Fields of papers citing papers by Mari Nakayama
This network shows the impact of papers produced by Mari Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Nakayama. The network helps show where Mari Nakayama may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Mari Nakayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 1 | |
| 2 | 2009 | 209 | |
| 3 | 2003 | 55 | |
| 4 | 2002 | 23 | |
| 5 | 2001 | 35 | |
| 6 | 2001 | 43 | |
| 7 | 2001 | 8 | |
| 8 | 2001 | 13 | |
| 9 | 2000 | 4 | |
| 10 | 2000 | 32 | |
| 11 | 1999 | 44 | |
| 12 | 1999 | 29 | |
| 13 | 1998 | 6 | |
| 14 | 1998 | 5 |
About Mari Nakayama
Mari Nakayama is a scholar working on Biochemistry, Immunology and Allergy and Pharmaceutical Science, having authored 14 papers that have together received 507 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Renin-Angiotensin System Studies (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), CRISPR and Genetic Engineering (2 papers), Receptor Mechanisms and Signaling (2 papers), Glycosylation and Glycoproteins Research (1 paper), Cholesterol and Lipid Metabolism (1 paper) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Biochemistry (36 citations), Toxicology (15 citations) and Biochemistry (25 citations). Mari Nakayama has collaborated with scholars based in Japan and United States. Frequent co-authors include Noboru Fukuda, Hirobumi Kishioka, Katsuo Kanmatsuse, Wen-Yang Hu, Masayuki Yamamoto, Akinori Yanaka, Atsushi Fukumoto, Songhua Zhang, Masafumi Tauchi and Hideo Suzuki. Their work appears in journals such as Macromolecules, Arteriosclerosis Thrombosis and Vascular Biology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.